The initial biopsy Gleason score as a predictive marker for docetaxel survival benefit in patients with prostate cancer: Data from the TAX 327 study

被引：4
|
作者：
van Soest, Robert
de Morree, Ellen
Shen, Liji
Tannock, Ian
Eisenberger, Mario A.
De Wit, Ronald
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Sanofi, Malvern, PA USA
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer
    Seo, Ji Won
    Shin, Su-Jin
    Oh, Young Taik
    Jung, Dae Chul
    Cho, Nam Hoon
    Choi, Young Deuk
    Park, Sung Yoon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (01) : W1 - W9
  • [42] No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancer
    Tanaka, Masatoshi
    Kimura, Takahiro
    Iwamura, Yumina
    Enei, Yuki
    Iwamoto, Yuya
    Imai, Yu
    Inaba, Yuzo
    Matsukawa, Akihiro
    Onuma, Hajime
    Ito, Kagenori
    Mori, Keiichiro
    Sasaki, Hiroshi
    Miki, Jun
    Furuta, Akira
    Miki, Kenta
    Egawa, Shin
    PROSTATE, 2019, 79 (14): : 1604 - 1610
  • [43] The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
    Wang, Hanfeng
    Gu, Liangyou
    Wu, Yongjie
    Feng, Dan
    Duan, Junyao
    Wang, Xiaocong
    Huang, Yong
    Wu, Shengpan
    Chen, Jianwen
    Luo, Guangda
    Zhang, Xu
    BMC CANCER, 2017, 17
  • [44] Biochemical survival for patients with gleason score 8 and 9 prostate cancer and PSA <20 following permanent prostate brachytherapy
    Merrick, G
    Butler, W
    Adamovich, E
    Galbreath, R
    MEDICAL PHYSICS, 2003, 30 (06) : 1467 - 1467
  • [45] The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
    Hanfeng Wang
    Liangyou Gu
    Yongjie Wu
    Dan Feng
    Junyao Duan
    Xiaocong Wang
    Yong Huang
    Shengpan Wu
    Jianwen Chen
    Guangda Luo
    Xu Zhang
    BMC Cancer, 17
  • [46] PREDICTION OF OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS DIAGNOSED WITH PROSTATE CANCER OF BIOPSY GLEASON SCORE ≥ 8 VIA CONTEMPORARY MULTI(≥12)-CORE PROSTATE BIOPSY
    Loeb, Stacy
    BJU INTERNATIONAL, 2011, 108 (02) : 222 - 222
  • [47] Quality of life (QOL) of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) following treatment with docetaxel or mitoxantrone in the TAX-327 study.
    Pond, G. R.
    Berthold, D. R.
    Dewit, R.
    Eisenberger, M.
    Tannock, I. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 230S - 230S
  • [48] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    William D. Figg
    Michael E. Franks
    David Venzon
    Paul Duray
    Michael C. Cox
    W. Marston Linehan
    W. Van Bingham
    James A. Eastham
    Eddie Reed
    Oliver Sartor
    World Journal of Urology, 2004, 22 : 425 - 430
  • [49] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    Figg, WD
    Franks, ME
    Venzon, D
    Duray, P
    Cox, MC
    Linehan, WM
    Van Bingham, W
    Eastham, JA
    Reed, E
    Sartor, O
    WORLD JOURNAL OF UROLOGY, 2004, 22 (06) : 425 - 430
  • [50] The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer
    Bian, Xiao-Jie
    Zhu, Yao
    Shen, Yi-Jun
    Wang, Jin-You
    Ma, Chun-Guang
    Zhang, Hai-Liang
    Dai, Bo
    Zhang, Shi-Lin
    Yao, Xu-Dong
    Ye, Ding-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (05) : 679 - 684
12345